TABLE OF CONTENTS
Volume 14, Issue 7 (July 2007)
Review
Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy
Z R Yang, H F Wang, J Zhao, Y Y Peng, J Wang, B-A Guinn and L Q Huang
Cancer Gene Ther 14: 599-615; advance online publication, April 20, 2007; doi:10.1038/sj.cgt.7701054
Original Articles
Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis
E T H Ek, C R Dass, K G Contreras and P F M Choong
Cancer Gene Ther 14: 616-626; advance online publication, May 4, 2007; doi:10.1038/sj.cgt.7701044
Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment
D Hoffmann and O Wildner
Cancer Gene Ther 14: 627-639; advance online publication, May 4, 2007; doi:10.1038/sj.cgt.7701055
Cytosine deaminase/5-fluorocytosine gene therapy and Apo2L/TRAIL cooperate to kill TRAIL-resistant tumor cells
J Wei, J Wahl, H Knauss, S Zeller, G Jarmy, G Fitze, K-M Debatin and C Beltinger
Cancer Gene Ther 14: 640-651; advance online publication, April 20, 2007; doi:10.1038/sj.cgt.7701051
An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells
C Y-F Lee, L X Bu, P S Rennie and W W-G Jia
Cancer Gene Ther 14: 652-660; advance online publication, April 20, 2007; doi:10.1038/sj.cgt.7701052
Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-
gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors
Z Ye, M Shi, T Chan, S Sas, S Xu and J Xiang
Cancer Gene Ther 14: 661-675; advance online publication, May 4, 2007; doi:10.1038/sj.cgt.7701039
